NATHBIOGEN

Nath Bio-Genes (India) financials

Market cap
₹290 Cr
Sector
Fast Moving Consumer Goods
Calls analysed
3
Latest concall · Q4 FY26 · call held 05 May 2026

Nath Bio-Genes Q4 FY26

Revenue ₹431.6 cr +19%EBITDA ₹52.5 cr EBITDA Margin 12% PAT ₹38.4 cr −8%

What went well

  • Total revenue grew 19% YoY to INR 431.6 crores.
  • Paddy value rose 37% YoY.
  • Maize volumes surged 54% YoY, with value growth of 78%, contributing 10.72% to top line.

What to watch

  • Gross margin normalized to 56% from an elevated 63% in FY25.
  • PAT declined 8% YoY to INR 38.4 crores, partly due to tax rate increase from 5% to 11% and higher finance costs.
Read the full call →

What Nath Bio-Genes (India) Limited does

Nath Bio-Genes researches, breeds and produces hybrid seeds for field crops (cotton, paddy, wheat, maize, bajra) and vegetables (tomato, chili, cucumber, okra) under brand names such as Sanket, Jumbo, Super-27 and Akhand, sold to farmers via a network of distributors and dealers. It also makes plant-nutrition/bio-stimulant products (Win-Chi-Win, Windrow GOLii, Winhall Granules) for soil health and productivity. The company is extending its reach internationally through a joint venture in Uzbekistan and regulatory approval efforts for commercial sales in the Philippines.

Segments

  • Field Crops
  • Vegetables
  • Plant Nutrition
  • International
Distributor & dealer network
~20,000
Branch offices
17
Processing plants
10
States covered
23
Cold storage, warehouse & conditioning godown capacity
25,000 MT
R&D infrastructure
DSIR-recognized R&D innovation centres
Headquarters Chhatrapati Sambhajinagar (Aurangabad), Maharashtra Company website

Guidance record · Q4 FY26

what the last two calls moved 8 tracked 1 delivered 3 missed 4 open
  • Revenue Growth delivered said Q4 FY25 Promised: 15% revenue growth for this year (FY26) Q4 FY26: Achieved. Full year FY26 revenue grew 19% YoY to INR 431.6 crores, exceeding the 15% target.
  • EBITDA/PBT Margin missed said Q4 FY25 Promised: Increase about 2 to 3 basis points Q4 FY26: Missed. Gross margin compressed to 56% from 63% in FY25. EBITDA margin for FY26 was 12%, and PAT margin fell to 9%. Management attributed the drop to higher finance and marketing costs.
  • Total Sales on track said Q4 FY25 Promised: Cross INR 500 crores in a year or 2 Q4 FY26: FY26 sales were INR 431.6 crores, crossing the INR 400 crore prerequisite mentioned in Q2. Management reiterated the goal, stating they 'hope to cross INR 500 crores of top line soon.'

All 8 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue up 15.4%, net profit up 13.8% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue32 37 49 280 40 +25%66 +78%46 −6%323 +15%
EBITDA7 8 3 30 7 +0%9 +13%7 +133%35 +17%
Net profit3 3 5 29 4 +33%7 +133%4 −20%33 +14%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −10.1% 1Y

₹140₹160₹180₹200Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q2 FY26 — 14 Nov 2025Q4 FY26 — 5 May 2026

1Y: ₹164.45 on 10 Sept 2025 → ₹147.78. High ₹196.01 (30 Apr 2026), low ₹129.02 (30 Mar 2026).

How the price took the results

close before → close after

Q4 FY26
−8.4%
5 May
Q2 FY26
+1.3%
14 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue grew 12.8% a year over 3 years, FY23 to FY26. Operating margin narrowed to 12.3%.

Year endingFY23FY24FY25FY26
Revenue₹301 Cr₹333 Cr₹362 Cr₹432 Cr
Operating profit₹48 Cr₹52 Cr₹55 Cr₹53 Cr
Operating margin16.1%15.6%15.2%12.3%
Interest₹10 Cr₹9 Cr₹9 Cr₹13 Cr
Depreciation₹3 Cr₹4 Cr₹4 Cr₹4 Cr
Net profit₹35 Cr₹42 Cr₹45 Cr₹44 Cr
Net margin11.8%12.6%12.4%10.2%
Cash from operations₹38 Cr₹75 Cr₹27 Cr₹-14 Cr
Free cash flow₹36 Cr₹48 Cr₹19 Cr₹-17 Cr
ROCE7.0%7.0%7.0%7.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹19 Cr₹19 Cr₹19 Cr₹19 Cr₹19 Cr₹19 Cr
Reserves₹594 Cr₹523 Cr₹554 Cr₹592 Cr₹668 Cr₹670 Cr
Borrowings₹101 Cr₹93 Cr₹105 Cr₹108 Cr₹142 Cr₹122 Cr
Other liabilities₹75 Cr₹105 Cr₹114 Cr₹158 Cr₹176 Cr₹272 Cr
Total liabilities₹790 Cr₹740 Cr₹793 Cr₹877 Cr₹1.0k Cr₹1.1k Cr
Fixed assets₹247 Cr₹245 Cr₹244 Cr₹249 Cr₹249 Cr₹249 Cr
Capital work in progress₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr
Other assets₹538 Cr₹490 Cr₹544 Cr₹622 Cr₹750 Cr₹827 Cr
Total assets₹790 Cr₹740 Cr₹793 Cr₹877 Cr₹1.0k Cr₹1.1k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public added +2.40 pp while DIIs trimmed −2.24 pp. The shareholder count shrank 5% to 32,564.

Promoters
45.6%
FIIs
0.3%
DIIs
0.0%
Public
54.1%

Since Jun 2025

  • Public +2.40 pp
  • DIIs −2.24 pp
  • FIIs −0.15 pp

How it drifted, 12 quarters

Over this window DIIs fell from 4.4% to 0.0% — −4.4 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 45.6%, FIIs 0.2%, DIIs 4.4%, Public 49.8%.Dec '23: Promoters 45.6%, FIIs 0.3%, DIIs 4.4%, Public 49.7%.Mar '24: Promoters 45.6%, FIIs 0.3%, DIIs 4.4%, Public 49.8%.Jun '24: Promoters 45.6%, FIIs 0.2%, DIIs 4.4%, Public 49.8%.Sep '24: Promoters 45.6%, FIIs 0.2%, DIIs 4.4%, Public 49.8%.Dec '24: Promoters 45.6%, FIIs 0.2%, DIIs 4.4%, Public 49.8%.Mar '25: Promoters 45.6%, FIIs 0.2%, DIIs 3.9%, Public 50.2%.Jun '25: Promoters 45.6%, FIIs 0.4%, DIIs 2.3%, Public 51.7%.Sep '25: Promoters 45.6%, FIIs 0.3%, DIIs 0.8%, Public 53.3%.Dec '25: Promoters 45.6%, FIIs 0.3%, DIIs 0.0%, Public 54.1%.Mar '26: Promoters 45.6%, FIIs 0.2%, DIIs 0.0%, Public 54.2%.Jun '26: Promoters 45.6%, FIIs 0.3%, DIIs 0.0%, Public 54.1%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of Nath Bio-Genes (India) Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Ashu Farms Llp 13.68%unchanged
Akash Farms Llp 12.24%unchanged
Mayo Farms Llp 5.72%unchanged
Tapovan Farms Llp 5.09%unchanged
Emerald Seeds Private Limited 3.63%unchanged
Tingli Finvest Pvt Ltd 2.96%unchanged
Nath Industries Limited 2.80%unchanged
Seetha Kumari 2.79%unchanged
Barkha Farms Llp 2.75%unchanged
Nath Royal Ltd 2.60%unchanged
Satpal Khattar 2.10%unchanged
Ferry Fax Farms Private Limited 1.62%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Fair

To justify its price of ₹148, this stock must grow earnings at -5% every year for 7 years. Our analysis caps realistic growth at ~-4%. At that growth it is worth ₹159 — upside of 8%.

Growth the price implies
-5.1% a year
for 7 years, fading to 4%
It has actually compounded at
-4.3% a year
net profit, FY23–FY26 · EPS -3.7%
The gap
-0.0 pp
8% downside if it only repeats history
Price today ₹147.78 Value at the reference growth ₹159.35

Change the assumptions yourself →

All earnings calls (3)

Read the Q4 FY26 call →

Learn to analyse Nath Bio-Genes (India) Limited

Guides on how to read this kind of business and the numbers that matter.